• 1.

    Wang L, et al. Calcineurin (CN) activation promotes apoptosis of glomerular podocytes both in vitro and in vivo. Mol Endocrinol 2011; 25:13761386. doi: 10.1210/me.2011-0029

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    Shen X, et al. Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models. Sci Rep 2016; 6:32087. doi: 10.1038/srep32087

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    Li Y, et al. Pharmacokinetic disposition difference between cyclosporine and voclosporin drives their distinct efficacy and safety profiles in clinical studies. Clin Pharmacol 2020; 12:8396. doi: 10.2147/CPAA.S255789

    • Search Google Scholar
    • Export Citation
  • 4.

    Sanders ML, Langone AJ. Drugs in development for prophylaxis of rejection in kidney-transplant recipients. Transpl Res Risk Manag 2015; 7:5969. doi: 10.2147/TRRM.S61446; https://www.dovepress.com/drugs-in-development-for-prophylaxis-of-rejection-in-kidney-transplant-peer-reviewed-fulltext-article-TRRM

    • Search Google Scholar
    • Export Citation
  • 5.

    Rovin BH, et al. A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis. Kidney Int 2019; 95:219231. doi: 10.1016/j.kint.2018.08.025

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Rovin BH, et al. Management of lupus nephritis (LN) with voclosporin: An update from a pooled analysis of 534 patients. American Society of Nephrology Kidney Week 2020. October 22, 2020. Abstract PO1917. https://www.asn-online.org/education/kidneyweek/2020/program-abstract.aspx?controlId=3446491

    • Search Google Scholar
    • Export Citation
  • 7.

    Arriens C, et al. Scientific Abstracts, Oral Presentations: Other orphan diseases. OP0277: AURORA phase 3 study demonstrates voclosporin statistical superiority over standard of care in lupus nephritis (LN). Ann Rheum Dis 2020; 79:172173. https://ard.bmj.com/content/79/Suppl_1/172.2

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Bensman A, Niaudet P. Non-immunologic mechanisms of calcineurin inhibitors explain its antiproteinuric effects in genetic glomerulopathies. Pediatr Nephrol 2010; 25:11971199. doi: 10.1007/s00467-010-1469-2

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Furie R, et al. Two-year, randomized, controlled trial of belimumab in lupus nephritis. N Engl J Med 2020; 383:11171128. doi: 10.1056/NEJMoa2001180

Voclosporin: Hope on the Horizon for Lupus Nephritis?

  • 1 Anna Gaddy, MD, is a nephrology fellow at Indiana University School of Medicine, Indianapolis.
Restricted access
Save